<scp>EFNS</scp>‐<scp>ENS</scp>/<scp>EAN</scp> Guideline on concomitant use of cholinesterase inhibitors and memantine in moderate to severe Alzheimer's disease
R. Schmidt(Medical University of Graz), Sandro Sorbi(University of Florence), Philip Scheltens(Amsterdam University Medical Centers), José Luís Molinuevo(Pasqual Maragall Foundation), Dorota Religa(Karolinska Institutet), Femke H. Bouwman(Amsterdam UMC Location Vrije Universiteit Amsterdam), Jonathan M. Schott(UK Dementia Research Institute), Katharina Büerger(German Center for Neurodegenerative Diseases), Tormod Fladby(University of Oslo), Charlotte Cordonnier(Inserm), Michael T. Heneka(University of Massachusetts Chan Medical School), Jakub Hort(Charles University), Daniela Galimberti(University of Milan), Jan Laczó(Charles University), Edith Hofer(Medical University of Graz), Jean Georges(Alzheimer Europe), John T. O’Brien(North Tyneside General Hospital)
Cited by 135
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k
Diagnosis and management of dementia with Lewy bodies
|Neurology|2017|4.4k
Consistent resting-state networks across healthy subjects
|Proceedings of the National Academy of Sciences|2006|4.4k